MoonLake Immunotherapeutics | ARS: Annual Report to Security Holders
MoonLake Immunotherapeutics | DEFA14A: Others
MoonLake Immunotherapeutics | DEF 14A: Definitive information statements
MoonLake Immunotherapeutics | 8-K: Current report
MoonLake Immunotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF PARTNERS L.P.(34.6%),BVF INC.(34.6%), etc.
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 10-K: Annual report
MoonLake Immunotherapeutics | 8-K: Current report
MoonLake Immunotherapeutics | 8-K: Current report
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merck Healthcare KGaA, Darmstadt Germany an affiliate of Merck KGaA, Darmstadt, Germany(4.7%),Merck KGaA, Darmstadt, Germany(4.7%), etc.
MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bihua Chen(14.17%)
MoonLake Immunotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.419%),Abigail P. Johnson(6.419%)
No Data